Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108966) titled 'CYP3A5 Genotype and Hyperglycemia in Kidney Transplant' on April 21.

Study Type: Observational

Study Design: Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: InvestigatorInitiated Study

Condition: Health Condition 1: N186- End stage renal disease

Intervention: Intervention1: Nil: Nil Intervention2: Nil: Nil

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 29-05-2026

Target Sample Size: 60

Countries of Recruitment: India

To know more, visit http://www.ct...